NEXGEL, Inc.
NASDAQ: NXGLW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Adam R. Levy
- Employees
- 19
- Headquarters
- Langhorne, United States
- IPO year
- 2021
- Market cap
- $3.0M
- Website
- https://nexgel.com
Loading NXGLW…
Loading profile data…Frequently asked questions about NXGLW
What does NEXGEL, Inc. (NXGLW) do?
NEXGEL, Inc. is a company that manufactures specialized hydrogels and gels, notable for their high water content, electron beam cross-linking, and aqueous polymer base. These advanced materials are widely utilized across several sectors, including wound care, medical diagnostics, transdermal drug delivery systems, and various cosmetic applicatio...
Where does NXGLW trade?
NEXGEL, Inc. (NXGLW) trades on the NASDAQ Capital Market.
What sector is NXGLW in?
NEXGEL, Inc. (NXGLW) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of NEXGEL, Inc.?
Adam R. Levy is the chief executive officer of NEXGEL, Inc. (NXGLW).
Where is NEXGEL, Inc. headquartered?
NEXGEL, Inc. is headquartered in United States.
Does NXGLW pay a dividend?
NEXGEL, Inc. (NXGLW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NXGLW go public?
NEXGEL, Inc. (NXGLW) completed its initial public offering in 2021.